retatrutide triple agonist peptide Retatrutide — Triple Agonist (GIP/GLP-1/Glucagon)

Compared to peptides like semaglutide or tirzepatide, retatrutide shows promising results in helping people shed fat more quickly

Please continue to direct any renewal decisions or new business submissions to our team via [email protected] or our secure upload link for processing

This is likely caused by the glucagon receptor component

It is plausible that retatrutide could offer similar benefits in this group given its potent metabolic effects, but this has not been directly studied

It targets the brains reward and hunger circuits rather than the central nervous systems stimulant receptors, so most patients describe the effect as quieter cravings rather than a jolt of energy

If GLP-1 medications caused thyroid problems in humans at meaningful rates, a study this large and long would have detected it